Ceftolozane-Tazobactam for Febrile Neutropenia Treatment in Hematologic Malignancy Patients Colonized by Multi-Resistant Enterobacteriaceae: Preliminary Results from a Prospective Cohort Study

Mediterr J Hematol Infect Dis. 2020 Sep 1;12(1):e2020065. doi: 10.4084/MJHID.2020.065. eCollection 2020.

¹ Hematology and Stem Cell Transplant Unit, I.R.C.C.S. Regina Elena National Cancer Institute (Rome, Italy).
² Department of Research, Advanced Diagnostics, and Technological Innovation, Translational Research Area, I.R.C.C.S. Regina Elena National Cancer Institute (Rome, Italy).
³ Microbiology and Virology, I.R.C.C.S. San Gallicano Dermatological Institute (Rome, Italy).
⁴ Biostatistics and Bioinformatic Unit, Scientific Direction, I.R.C.C.S. Regina Elena National Cancer Institute (Rome Italy).

No abstract available

Keywords: Carbapenem-sparing; Ceftolozane-Tazobactam; Febrile neutropenia; Hematologic malignancy.